methotrexate has been researched along with Acute Relapsing Multiple Sclerosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedetti, MD; Invernizzi, P; Monaco, S; Poli, S | 1 |
| Apperson-Hansen, C; Beck, GJ; Calabresi, PA; Cohen, JA; Edwards, KR; Eickenhorst, T; Felton, WL; Fisher, E; Fox, RJ; Goodman, AD; Hara-Cleaver, C; Houghtaling, PL; Hutton, GJ; Imrey, PB; Karafa, MT; Mandell, BF; Scott, TF; Stadtler, M; Zhang, H | 1 |
| Hartung, HP; Kieseier, BC | 1 |
| Amory, JK; Kalus, RM; Saint, S; Shojania, KG | 1 |
| Ahmed, A; Ali, S; Asif, M; Fredrikson, S; Haq, A; Hassan, A; Khatri, IA; Khealani, B; Malik, A; Wasay, M; Zakiullah, N | 1 |
| Chaperon, J; Coustans, M; Edan, G; Le Page, E; Leray, E; Morrissey, SP; Taurin, G | 1 |
| Calabresi, PA; Chakraborty, S; Cohen, JA; Edwards, KR; Eickenhorst, T; Felton, WL; Fisher, E; Fox, RJ; Goodman, AD; Hara-Cleaver, C; Hutton, GJ; Imrey, PB; Ivancic, DM; Mandell, BF; Perryman, JE; Scott, TF; Skaramagas, TT; Zhang, H | 1 |
| Calabresi, PA; Mills, P; Rogg, JM; Webb, A; Whartenby, KA; Wilterdink, JL | 1 |
2 review(s) available for methotrexate and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Azathioprine in multiple sclerosis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Chemistry, Pharmaceutical; Cyclophosphamide; Drug Design; Fingolimod Hydrochloride; Humans; Immunologic Factors; Immunosuppressive Agents; Methotrexate; Methyltransferases; Mitoxantrone; Models, Chemical; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Propylene Glycols; Sphingosine | 2008 |
Current disease-modifying therapies in multiple sclerosis.
Topics: Adjuvants, Immunologic; Analgesics; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclophosphamide; Cyclosporine; Glatiramer Acetate; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Peptides; Plasma Exchange | 2003 |
4 trial(s) available for methotrexate and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Anti-Inflammatory Agents; Cooperative Behavior; Data Interpretation, Statistical; Disability Evaluation; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Patient Selection; Treatment Outcome | 2009 |
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Azathioprine; Brain; Demography; Disability Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Relapsing-Remitting; Observation; Peptides; Prevalence; Recurrence | 2008 |
Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Anti-Inflammatory Agents; Cooperative Behavior; Data Interpretation, Statistical; Disability Evaluation; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Patient Selection; Treatment Outcome | 2008 |
An open-label trial of combination therapy with interferon beta-1a and oral methotrexate in MS.
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pilot Projects | 2002 |
2 other study(ies) available for methotrexate and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Clinical problem-solving. Lost in transcription.
Topics: Bone Marrow; Diagnosis, Differential; Female; Fever; Hematuria; Humans; Immunosuppressive Agents; Leukopenia; Medical Records Systems, Computerized; Medication Errors; Methotrexate; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Thrombocytopenia; Urinary Catheterization; Urination Disorders | 2006 |
Multiple sclerosis in Pakistan.
Topics: Adolescent; Adult; Antineoplastic Agents; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Optic Neuritis; Pakistan; Prevalence; Retrospective Studies; Steroids | 2007 |